Handa Oncology Receives FDA Final Approval for OMCAZIO(TM) (cabozantinib) Capsules

OMCAZIO approved for administration without regard to food, removing strict fasting requirements for cabozantinib patients SAN JOSE, CA AND TAIPEI, TW / ACCESS Newswire / September 11, 2026 / Handa Pharmaceuticals, Inc. ("Handa" or the "Company") …